MedPath

Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Conditions
Severe Sepsis Without Septic Shock
Severe Sepsis
Registration Number
NCT05304728
Lead Sponsor
Beckman Coulter, Inc.
Brief Summary

This protocol will collect real-world data retrospectively from the electronic health record (EHR) as data obtained from the delivery of routine medical care to develop a machine learning (ML)-based Clinical Decision Support (CDS) system for severe sepsis prediction and detection.

Detailed Description

The purpose of this study is to gather data for the clinical development of the Sepsis Onset Warning System (SOWS) Software as Medical Device (SaMD) product to support a De Novo FDA submission and commercialization in the United States. Product development of SOWS is funded in part with federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority.

Data will be obtained from passive prospective collection of patient encounter data throughout the duration of the planned study to support the product development life cycle activities associated with developing the Sepsis Onset Warning System (SOWS) for severe sepsis risk detection. Inputs from patient health records in combination with proprietary hematology parameters developed by Beckman Coulter, such as Monocyte Distribution Width (MDW), will be used. The SOWS tool will look to use clinical measurements which are commonly and reliably available in the EHR as structured data elements, such as heart rate, temperature, blood pressure, and laboratory results and account for changes in these values over time.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
40000
Inclusion Criteria
  • All races, ages and ethnicities
  • All patients admitted to the hospital or presenting to the Emergency Department
Exclusion Criteria
  • Patients not presenting to a hospital setting (e.g. urgent care, outpatient clinic excluded).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severe SepsisWithin 6 hours from presentation to the emergency department

Identify patients having Severe Sepsis with the use of electronic health data

Secondary Outcome Measures
NameTimeMethod
MortalityWithin 6hours from presentation to the emergency department

Hospital mortality at hospital for Severe Sepsis patients identified by algorithm using electronic health data as potential benefits for increased early detection of risk of severe sepsis

Length of StayWithin 6hours from presentation to the emergency department

Determine length of stay at hospital for Severe Sepsis patients identified by algorithm using electronic health data as potential benefits for increased early detection of risk of severe sepsis

Re-admission RatesWithin 6hours from presentation to the emergency department

Determine potential reduction of hospital readmission rates for Severe Sepsis patients identified by algorithm using electronic health data as potential benefits for increased early detection of risk of severe sepsis

Trial Locations

Locations (10)

University of California, Irvine

🇺🇸

Irvine, California, United States

The Ohio State University

🇺🇸

Columbus, Ohio, United States

Augusta University Medical School

🇺🇸

Augusta, Georgia, United States

MetroHealth Systems

🇺🇸

Cleveland, Ohio, United States

Indiana University Health

🇺🇸

Indianapolis, Indiana, United States

WakeMed Health

🇺🇸

Raleigh, North Carolina, United States

University of Cininnati

🇺🇸

Cincinnati, Ohio, United States

Hackensack University Medical Center

🇺🇸

Hackensack, New Jersey, United States

University Health/ Truman Medical Center

🇺🇸

Kansas City, Missouri, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath